The human papillomavirus vaccine: A powerful tool for the primary prevention of cervical cancer.
Prevention & control Cervix neoplasms prevention Uterine cervical neoplasms Papillomavirus vaccines Oncogenic viruses Condylomata acuminata Warts Vulvar neoplasms Vaginal neoplasms
Main Article Content
Prophylactic human papillomavirus (HPV) vaccine is the most promissory public health tool for primary prevention of cervical cancer. Immunization of females before the acquisition of HPV infection has the greatest impact in preventing pre-neoplasic lesions and cervical cancer. Current HPV vaccines do not eliminate cervical cancer risk, therefore, screening should continue covering vaccinated as well as women that do not get the vaccine. The strategies that include combination of high-coverage vaccination of HPV-unexposed adolescents with screening using methods with higher sensitivity than cytology as HPV test may be more cost-effective than the strategies currently used. The cytology-based screening programs of Latin America countries including Colombia are very ineffective. The evidence in favor of the cost-effectiveness of other screening strategies such as HPV tests and visual inspection followed by immediate treatment for women with difficult access to health care services in developing countries warrants the immediate revision of the current strategies.
Muñoz, N., Reina, J. C., & Sánchez, G. I. (2008). The human papillomavirus vaccine: A powerful tool for the primary prevention of cervical cancer. Colombia Médica, 39(2), 196–202. https://doi.org/10.25100/cm.v39i2.577
Downloads
Download data is not yet available.
- Luis Eduardo Bravo, Nubia Muñoz, Epidemiology of cancer in Colombia , Colombia Médica: Vol. 49 No. 1 (2018): Colombia Cancer Epidemiology
- Nubia Muñoz, COVID-19 in Latin America: a first glance to the mortality , Colombia Médica: Vol. 51 No. 2 (2020): Coronavirus disease 2019
- Nubia Muñoz, Luis Eduardo Bravo, Epidemiology of cervical cancer in Colombia , Colombia Médica: Vol. 43 No. 4 (2012): Numbers in cancer: 50-year of The Population-based Cancer Registry of Cali
- Julio Cesar Reina, Nubia Muñoz, Vaccine against human Papilloma Virus , Colombia Médica: Vol. 45 No. 3 (2014)
- Julio César Reina, Nubia Muñoz, Gloria Inés Sánchez, State-of-the-art of infections produced by human papillomavirus. , Colombia Médica: Vol. 39 No. 2 (2008)
- Julio César Reina, Héctor J Gómez, Tratamiento de hipertensión refractaria en un niño , Colombia Médica: Vol. 7 No. 3 (1976)
- Stephen Berman, Alberto Levy, Julio César Reina, Hemocultivos en niños con sospecha de sepsis en urgencias Hospital Universitario del Valle , Colombia Médica: Vol. 9 No. 3,4 (1978)
- Julio César Reina, Nefrotoxicidad por antibióticos en niños , Colombia Médica: Vol. 22 No. 2 (1991)
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use